Overview
O'Sullivan-McLeod syndrome is a rare, slowly progressive form of spinal muscular atrophy (also classified under distal hereditary motor neuronopathy) that predominantly affects the small muscles of the hands. First described by O'Sullivan and McLeod in 1978, this condition is characterized by progressive wasting and weakness of the thenar and hypothenar muscles (the muscles at the base of the thumb and little finger), as well as the intrinsic hand muscles, leading to difficulty with fine motor tasks such as gripping, writing, and manipulating small objects. The condition primarily affects the lower motor neurons that innervate the distal upper extremities, and it is notable for its very slow progression and relatively benign course compared to other motor neuron diseases. The syndrome typically presents in young adulthood, most commonly in women, and is distinguished from other forms of spinal muscular atrophy by its restriction to the hands and distal upper limbs, with little or no involvement of the lower extremities or proximal muscles. Sensory function is preserved, and there are no upper motor neuron signs, distinguishing it from amyotrophic lateral sclerosis (ALS). Electromyography (EMG) typically shows chronic denervation changes in the affected hand muscles, while nerve conduction studies remain relatively normal, confirming the motor neuron origin of the disease. There is currently no curative treatment for O'Sullivan-McLeod syndrome. Management is supportive and focuses on occupational therapy to maintain hand function, adaptive devices to assist with daily activities, and regular neurological monitoring to track disease progression. The prognosis is generally favorable, as the disease tends to progress very slowly and does not significantly affect life expectancy. The underlying genetic cause has not been definitively established, and many cases appear to be sporadic.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for O'Sullivan-McLeod syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for O'Sullivan-McLeod syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for O'Sullivan-McLeod syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to O'Sullivan-McLeod syndrome.
Community
No community posts yet. Be the first to share your experience with O'Sullivan-McLeod syndrome.
Start the conversation →Latest news about O'Sullivan-McLeod syndrome
No recent news articles for O'Sullivan-McLeod syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about O'Sullivan-McLeod syndrome
What is O'Sullivan-McLeod syndrome?
O'Sullivan-McLeod syndrome is a rare, slowly progressive form of spinal muscular atrophy (also classified under distal hereditary motor neuronopathy) that predominantly affects the small muscles of the hands. First described by O'Sullivan and McLeod in 1978, this condition is characterized by progressive wasting and weakness of the thenar and hypothenar muscles (the muscles at the base of the thumb and little finger), as well as the intrinsic hand muscles, leading to difficulty with fine motor tasks such as gripping, writing, and manipulating small objects. The condition primarily affects the
How is O'Sullivan-McLeod syndrome inherited?
O'Sullivan-McLeod syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does O'Sullivan-McLeod syndrome typically begin?
Typical onset of O'Sullivan-McLeod syndrome is adult. Age of onset can vary across affected individuals.